Back to the search results

Ortenau Klinikum Lahr

Ortenau Klinikum Lahr
Ortenau Klinikum Lahr

Klostenstrasse 19
77933 Lahr

Phone: 07821-93-2001
Fax: 07821-93-2050
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

  • Number of beds: 441
  • Number of specialist departments: 13
  • Number of inpatient cases: 16.889
  • Number of partial inpatient cases: 82
  • Number of outpatient cases: 37.660
  • Hospital owners: Ortenaukreis
  • Type of provider: öffentlich
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Diabetes mellitus Typ 2

Die von der DDG geforderten Voraussetzungen (personelle, medizinische u. räumliche Ausstattung) werden in vollem Maß erfüllt. Für die Betreuung der Patienten Diabetes Typ 1 u. Typ 2 stehen zwei Diabetologen (DDG) u. zwei Diabetesberaterinnen (DDG) zur Verfügung. Wir arbeiten nach den Leitlinien der DDG u. nehmen zur Sicherung der Qualität regelmäßig an den entsprechenden Fortbildungen teil. Dieses Fachwissen kann von allen Pat. aller Fachabteilungen in Anspruch genommen werden.

Quantity performed 27
Exception? No exception
Quantity performed 116
Exception? No exception
Quantity performed 43
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 43
Quantity forecast year: 29
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 116
Quantity forecast year: 135
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 0
Quantity forecast year: 145
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 27
Quantity forecast year: 32
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
117 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
90 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
81 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

FO OG AP Arzneimittelkonsil 20210460

30.04.2021

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • CGM-Muse
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Comment

Aufgrund der Kooperation mit dem Ortenau Klinikum Offenburg besteht die Möglichkeit, den praktischen Teil der Ausbildung vor Ort am Ortenau Klinikum Lahr-Ettenheim zu absolvieren.

Comment

Comment

Die Hebammenschule in Lahr befindet sich in gemeinsamer Trägerschaft mit der DAA und dem Ortenau Klinikum. Der praktische Teil der Ausbildung kann vor Ort am Ortenau Klinikum Lahr-Ettenheim absolviert werden.

Comment

Gabriele Billion (seit 09/2020)

Patientenfürsprecherin

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-1030
Mail: ed.mukinilk-uanetro@el.ehcarpsreufnetneitap

Feedbackmanagement Nicole Wußler

QMB/ Feedbackmanagement

Klostenstrasse 19
77933 Lahr

Phone: 0781 -472-4953
Mail: ed.mukinilk-uanetro@tnemeganamkcabdeef

Karin vom Holt

Qualitätsmanagementbeauftragte

Klostenstrasse 19
77933 Lahr

Phone: 0781 -472-4950
Mail: ed.mukinilk-uanetro@tnemeganamsteatilauq

Prof. Dr. Lothar Tietze

Ärztlicher Direktor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2751
Mail: ed.mukinilk-uanetro@hal.eigolohtap

Prof. Dr. med Leonhard Mohr

Ärztlicher Direktor, Chefarzt Medizinische Klinik, Gastroenterologie, Endokrinologie, Diabetologie

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2400
Mail: ed.mukinilk-uanetro@hal.eigoloretneortsag

Christian Reiß

Chefapotheker

Klostenstrasse 19
77933 Lahr

Phone: 0781 -472-8000
Mail: ed.mukinilk-uanetro@ssieR.naitsirhC

Cristof Mutter

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2000
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Christof Mutter

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2000
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Kathleen Messer

Pflegedirektorin

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2221
Mail: ed.mukinilk-uanetro@el.noitkeridegelfp

Michael Goldt (ab 09/2019- 09/2020)

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2001
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Cristof Mutter (ab 10/2020)

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2000
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Christof Mutter

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2000
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Cristof Mutter

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2000
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Christof Mutter

Verwaltungsdirektor

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2000
Mail: ed.mukinilk-uanetro@el.noitkeridsgnutlawrev

Prof. Dr. Lothar Tietze

Ärztlicher Direktor, Chefarzt, Vertragsarzt für Pathologie

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2751
Mail: ed.mukinilk-uanetro@hal.eigolohtap

Prof. Dr. Lothar Tietze (bis 12.2021)

Ärztlicher Direktor, Chefarzt, Vertragsarzt für Pathologie

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2751
Mail: ed.mukinilk-uanetro@hal.eigolohtap

Prof. Dr. med. Leonhard Mohr (seit 01.2022)

Ärztlicher Direktor, Chefarzt, Medizinische Klinik, Gastroenterologie, Endokrinologie, Diabetologie

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2400
Mail: ed.mukinilk-uanetro@hal.eigoloretneortsag

Prof. Dr. med. Leonhard Mohr

Ärztlicher Direktor, Chefarzt, Medizinische Klinik, Gastroenterologie, Endokrinologie, Diabetologie

Klostenstrasse 19
77933 Lahr

Phone: 07821 -93-2400
Mail: ed.mukinilk-uanetro@hal.eigoloretneortsag

IK: 260833520

Location number: 771962000

Old location number: 771962000